Search All Resources
The Link Between Stigma and Health Inequities in Addiction | September 15, 2026
Type: Past Presentation
Audience: Clinical
Program: Advancing Pharmacist Roles in Substance Use Disorder Treatment and Recovery Teams
Keywords: #addiction #inequity #stigma #substance #SUD #use
In this presentation, Dr. Wartman explores the pervasive nature of stigma surrounding substance use disorders and its impact on individuals, families, communities, and health inequities. Dr. Wartman also examines factors that perpetuate stigma and create barriers to treatment and discusses ...
Date added: 09/10/26
Repurposing GLP-1 Receptor Agonists for Substance Use Disorders | August 18, 2026
Type: Past Presentation
Audience: Clinical
Program: Advancing Pharmacist Roles in Substance Use Disorder Treatment and Recovery Teams
Keywords: #alcohol #aud #disorder #glp #GLP-1 #nih #substance #SUD #use #weight
In this presentation, Dr. Weiss reviews the neurobiological rationale and emerging clinical evidence supporting the use of glucagon-like peptide-1 (GLP-1) receptor agonists for alcohol and other substance use disorders (SUDs). Dr. Weiss also discusses the efficacy, safety, and potential role ...
Date added: 08/7/26
Differences in Non-Suicidal Self-Injury (NSSI), Passive and Active Suicidal Ideation (SI) | July 21, 2026
Type: Past Presentation
Audience: Clinical
Program: Advancing Pharmacist Roles in Substance Use Disorder Treatment and Recovery Teams
Keywords: #active #behavioral #health #ideation #NSSI #passive #SI #substance #SUD #suicide
In this presentation, Dr. Perkins provides a clinically focused review of non-suicidal self-injury (NSSI), passive suicidal ideation, and active suicidal ideation (SI), emphasizing the key distinctions among these presentations. She also examines evidence-informed screening approaches to support accurate identification and ...
Date added: 07/12/26
Kratom & 7-OH: Understand the Metabolism, Withdrawal and Treatment of these OTC Products | June 16, 2026
Type: Past Presentation
Audience: Clinical
Program: Advancing Pharmacist Roles in Substance Use Disorder Treatment and Recovery Teams
In this presentation, Dr. Pies provides an overview of kratom and 7-hydroxymitragynine products, including key pharmacologic concepts, clinical risks, and implications for practice. Dr. Pies also reviews current approaches to recognizing and managing withdrawal, as well as evidence-based treatment strategies ...
Date added: 06/3/26
Introduction to Stimulant Use Disorders | May 19, 2026
Type: Past Presentation
Audience: Clinical
Program: Advancing Pharmacist Roles in Substance Use Disorder Treatment and Recovery Teams
Keywords: #overdose #overdose prevention #stimulant use disorder #stimulants #SUD #withdrawal
In this presentation, CDR Samantha Hoke introduces stimulant use disorders and their role in the overdose epidemic. She reviews how to recognize intoxication, overdose, and withdrawal, and outlines evidence-based treatments along with common co-occurring medical and psychiatric conditions.
Date added: 05/19/26
Nociplastic Pain | April 21, 2026
Type: Past Presentation
Audience: Clinical
Program: Advancing Pharmacist Roles in Substance Use Disorder Treatment and Recovery Teams
Keywords: #fibromyalgia #iasp #nociplastic #pain #taxonomy
In this presentation, Dr. Bettinger reviews the current pain taxonomy developed by the International Association for the Study of Pain (IASP), with a focus on nociplastic pain, and examines common patient presentations. He also discusses treatment approaches through clinical case examples ...
Date added: 04/6/26
Self-Care: Avoiding Secondary Trauma and Burnout – Part 2 | March 17, 2026
Type: Past Presentation
Audience: Clinical
Program: Advancing Pharmacist Roles in Substance Use Disorder Treatment and Recovery Teams
In this presentation, Anna Winters, CPRC, RCPF and Tracy Madden, CPRC, CPRM, RCPF of Peer 360 Recovery Alliance, explore strategies for recognizing and addressing secondary trauma and burnout while supporting long-term well-being in professional and personal life. They discuss applying ...
Date added: 03/16/26
Psychedelics for Addiction and Mental Health Treatment | February 17, 2026
Type: Past Presentation
Audience: Clinical
Program: Advancing Pharmacist Roles in Substance Use Disorder Treatment and Recovery Teams
Keywords: #addiction #health #mental #psychedelic #substance #SUD
In this presentation, Dr. Schachman provides an evidence-informed overview of psychedelic-assisted approaches to addiction and mental health treatment, acknowledging their ongoing use in community and cultural contexts. Dr. Schachman reviews historical and contemporary applications, underlying neurobiological mechanisms, current safety and ...
Date added: 02/17/26
Clinical Pharmacy Resources for Syndemic Services | January 20, 2026
Type: Past Presentation
Audience: Clinical
Program: Advancing Pharmacist Roles in Substance Use Disorder Treatment and Recovery Teams
Keywords: #clinical #pharmacy #resources #services #syndemic
In this presentation, Dr. Bethany Johnson, PharmD, BCIDP and CAPT Holly Van Lew, PharmD, BCPS, AAHIVP, provide an overview of clinical pharmacy resources supporting syndemic services, highlighting developed tools, professional advocacy efforts, and the role of pharmacy in delivering coordinated, ...
Date added: 01/12/26
Building a Bridge Clinic | December 16, 2025
Type: Past Presentation
Audience: Clinical
Program: Advancing Pharmacist Roles in Substance Use Disorder Treatment and Recovery Teams
Keywords: #bridge #bupe #buprenorphine #ed #emergency #er #mat #MOUD
In this presentation, Dr. Mega outlines how a Bridge Clinic can provide low-barrier, rapid-access follow-up for patients with substance use disorders (SUDs) after Emergency Department visits or inpatient stays. Dr. Mega describes why this model strengthens care systems and shares ...
Date added: 12/15/25
